ORGANIC
LETTERS
2010
Vol. 12, No. 15
3434-3437
Titanium-Mediated Spirocyclization
Reactions of 4-Alkylpyridines
Sharavathi G. Parameswarappa and F. Christopher Pigge*
Department of Chemistry, UniVersity of Iowa, Iowa City, Iowa 52242
Received June 1, 2010
ABSTRACT
Pyridines substituted at the 4-position with alkyl tethers containing ꢀ-dicarbonyl moieties were converted to spirocyclic 4,4-disubstituted
dihydropyridines. Optimal conditions for these transformations involved N-acylation of the pyridine substrate with a chloroformate electrophile
in the presence of Ti(OiPr)4. Cyclization products could be easily converted into spiro-piperidine derivatives or elaborated into more complex
heterocyclic frameworks via Au-catalyzed cycloisomerization.
Elaboration of pyridine ring systems offers convenient access
to a wealth of substituted aza-heterocyclic derivatives. In
particular, intermolecular addition of nucleophiles to acti-
vated N-alkyl- or N-acylpyridinium cations is well-estab-
lished, and the resulting 1,2- or 1,4-dihydropyridine products
can be converted into substituted piperidines, pyridines, and
other heterocyclic ring systems.1 In contrast, construction
of polycyclic heterocyclic frameworks via intramolecular
nucleophilic additions to pyridines or pyridinium salts is
much less common.2 Importantly, such reaction manifolds
provide concise entry to fused-ring and/or spirocyclic dihy-
dropyridine derivatives that are well-suited for further
synthetic manipulation.3 Moreover, spiropiperidine-based
ring systems are encountered in numerous bioactive materials
of potential pharmacological significance.4 Consequently,
further expansion of intramolecular reaction pathways avail-
able to substituted pyridines (particularly those leading to
spiro-dihydropyridine products) is of general interest to the
synthetic and medicinal chemistry communities.
Most spirocyclization reactions involving pyridine sub-
strates are initiated by alkylation or acylation of the pyridyl
nitrogen to afford electrophilic pyridinium cation intermedi-
(1) For recent examples of intermolecular nucleophilic additions to
activated pyridines, see: (a) McCall, W. S.; Grillo, T. A.; Comins, D. L. J.
Org. Chem. 2008, 73, 9744. (b) Gotchev, D. B.; Comins, D. L. J. Org.
Chem. 2006, 71, 9393. (c) Comins, D. L.; Sahn, J. J. Org. Lett. 2005, 7,
5227. (d) Lemire, A.; Charette, A. B. J. Org. Chem. 2010, 75, 2077. (e)
Barbe, G.; Pelletier, G.; Charette, A. B. Org. Lett. 2009, 11, 3398. (f)
Larive´e, A.; Charette, A. B. Org. Lett. 2006, 8, 3955. (g) Focken, T.;
Charette, A. B. Org. Lett. 2006, 8, 2985. (h) Andersson, H.; Banchelin,
T. S.-C.; Das, S.; Olsson, R.; Almqvist, F. Chem. Commun. 2010, 46, 3384.
(i) Donohoe, T. J.; Connolly, M. J.; Walton, L. Org. Lett. 2009, 11, 5562.
(j) Ferna´ndez-Iba´n˜ez, M. A.; Macia´, B.; Pizzuti, M. G.; Minnaard, A. J.;
Feringa, B. L. Angew. Chem., Int. Ed. 2009, 48, 9339. (k) Yamada, S.;
Inoue, M. Org. Lett. 2007, 9, 1477.
(3) Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141.
(4) (a) Wang, J.; Cady, S. D.; Balannik, V.; Pinto, L. H.; DeGrado,
W. F.; Hong, M. J. Am. Chem. Soc. 2009, 131, 8066. (b) Methot, J. L.;
Hamblett, C. L.; Mamprien, D. M.; Jong, J.; Harsch, A.; Szewczak, A. A.;
Dahlberg, W. K.; Middleton, R. E.; Hughes, B.; Fleming, J. C.; Wang, H.;
Kral, A. M.; Ozerova, N.; Cruz, J. C.; Haines, B.; Chenard, M.; Kenific,
C. M.; Secrist, J. P.; Miller, T. A. Bioorg. Med. Chem. Lett. 2008, 18, 6104.
(c) Xiao, D.; Palani, A.; Aslanian, R.; McKittrick, B. A.; McPhail, A. T.;
Correll, C. C.; Phelps, P. T.; Anthes, J. C.; Rindgen, D. Bioorg. Med. Chem.
Lett. 2009, 19, 783. (d) Oberdorf, C.; Schepmann, D.; Vela, J. M.; Diaz,
J. L.; Holenz, J.; Wu¨nsch, B. J. Med. Chem. 2008, 51, 6531. (e) Bienayme´,
H.; Cheˆne, L.; Grisoni, S.; Grondin, A.; Kaloun, E.-B.; Poigny, S.; Rahali,
H.; Tam, E. Bioorg. Med. Chem. Lett. 2006, 16, 4830. (f) Bondensgaard,
K.; Ankersen, M.; Thøgersen, H.; Hansen, B. S.; Wulff, B. S.; Bywater,
R. P. J. Med. Chem. 2004, 47, 888. (g) Kazmierski, W. M.; Furfine, E.;
Spaltenstein, A.; Wright, L. L. Bioorg. Med. Chem. Lett. 2002, 12, 3431.
(2) For examples of intramolecular nucleophilic additions to pyridines
leading to spiro-dihydropyridine products, see: (a) Brice, H.; Clayden, J.
Chem. Commun. 2009, 1964. (b) Arnott, G.; Brice, H.; Clayden, J.; Blaney,
E. Org. Lett. 2008, 10, 3089. (c) Arnott, G.; Clayden, J.; Hamilton, S. D.
Org. Lett. 2006, 8, 5325. (d) Goldmann, S.; Born, L.; Kazda, S.; Pittel, B.;
Schramm, M. J. Med. Chem. 1990, 33, 1413. (e) Weller, D. D.; Stirchak,
E. P.; Weller, D. L. J. Org. Chem. 1983, 48, 4597.
10.1021/ol1012636 2010 American Chemical Society
Published on Web 07/14/2010